ARA-290 – 5mg

ARA-290, also known as cibinetide, is a synthetic erythropoietin-derived peptide corresponding to the helix-B surface region of EPO. This molecule is indexed under PubChem CID: 118967673 and has been validated in peer-reviewed mechanistic studies such as PMID: 22198449, confirming its relevance in innate repair receptor (IRR)–associated biochemical pathways.

In controlled laboratory environments, ARA-290 is used to investigate tissue-protective signaling, anti-inflammatory mechanisms, and EPO receptor–related molecular interactions. Unlike full-length erythropoietin, ARA-290 does not activate classical erythropoiesis or hematopoietic receptor signaling. This distinction makes it a valuable research tool for differentiating hematopoietic vs. non-hematopoietic pathways, enabling clear mechanistic assessment of peptide-specific receptor engagement, IRR complex interactions, and downstream molecular effects.

Important Information About This Research Product:

• Your vials are not empty — the lyophilized material collects at the bottom.
• All products arrive as lyophilized powder requiring reconstitution.
• Bacteriostatic water is not supplied.
• Store in a cool, dry environment — short-term at 4°C, long-term at −20°C.
• This material is strictly for laboratory research use only. No instructions for reconstitution, dosing, or administration can be provided.